Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

AstraZeneca presents novel CDK9/cyclin T1 inhibitors

Jan. 19, 2017

Redx Pharma discovers new compounds promoting interferon alpha production

Jan. 19, 2017

Academia Sinica discloses new glucagon-like peptide 1 modulators

Jan. 19, 2017

SignalChem Lifesciences describes novel carbonic anhydrase 9, 12 inhibtors

Jan. 19, 2017

Exelixis discovers new S1P1 and S1P5 receptor agonists

Jan. 19, 2017

Orion presents novel bromodomain-containing protein 4 inhibitors

Jan. 18, 2017

GlaxoSmithKline describes new indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 18, 2017

Wockhardt presents novel bicyclic antibacterial activity enhancers

Jan. 18, 2017

Nimbus Therapeutics patents IRAK-4 inhibitors

Jan. 18, 2017

Merck & Co. discloses novel PI3Kdelta inhibtors

Jan. 18, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...